Literature DB >> 32572521

A novel de novo heterozygous ALPL nonsense mutation associated with adult hypophosphatasia.

L Martins1, E L Dos Santos1,2, A B de Almeida1, R A Machado3,4, A M Lyrio5, B L Foster2, K R Kantovitz6, R D Coletta3, F H Nociti7.   

Abstract

Using genetic, clinical, biochemical, and radiographic assessment and bioinformatic approaches, we present an unusual case of adult HPP caused by a novel de novo heterozygous nonsense mutation in the alkaline phosphatase (ALPL).
INTRODUCTION: Hypophosphatasia (HPP) is caused by genetic alterations of the ALPL gene, encoding the tissue-nonspecific isozyme of alkaline phosphatase (TNSALP). Here, the purpose was to perform clinical and molecular investigation in a 36-year-old Caucasian woman suspected to present adult HPP.
METHODS: Medical and dental histories were obtained for the proposita and family members, including biochemical, radiographic, and dental assessments. ALPL mutational analysis was performed by the Sanger sequencing method, and the functional impact prediction of the identified mutations was assessed by bioinformatic methods.
RESULTS: We identified a novel heterozygous nonsense mutation in the ALPL gene (NM_000478.6:c.768G>A; W[TGG]>*[TGA]) associated with spontaneous vertebral fracture, severe back pain, musculoskeletal pain, low bone density, and short-rooted permanent teeth loss. Functional prediction analysis revealed that the Trp256Ter mutation led to a complete loss of TNSALP crown domain and extensive loss of other functional domains (calcium-binding domain, active site vicinity, and zinc-binding site) and over 60% loss of homodimer interface residues, suggesting that the mutant TNSALP molecules are nonfunctional and form unstable homodimers. Genotyping of the ALPL in the proposita's parents, sister, and niece revealed that in this case, HPP occurred due to a de novo mutation.
CONCLUSION: The present study describes a novel genotype-phenotype and structure-function relationship for HPP, contributing to a better molecular comprehension of HPP etiology and pathophysiology.

Entities:  

Keywords:  3D modeling; Alkaline phosphatase; De novo mutation; Hypophosphatasia; Nonsense mutation

Mesh:

Substances:

Year:  2020        PMID: 32572521      PMCID: PMC8214176          DOI: 10.1007/s00198-020-05490-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  20 in total

1.  Mutational and biochemical findings in adults with persistent hypophosphatasemia.

Authors:  F E McKiernan; J Dong; R L Berg; E Scotty; P Mundt; L Larson; I Rai
Journal:  Osteoporos Int       Date:  2017-04-12       Impact factor: 4.507

Review 2.  Hypophosphatasia in Adults: Clinical Assessment and Treatment Considerations.

Authors:  Jay R Shapiro; E Michael Lewiecki
Journal:  J Bone Miner Res       Date:  2017-08-16       Impact factor: 6.741

Review 3.  Hypophosphatasia: clinical manifestation and burden of disease in adult patients.

Authors:  Francesco Conti; Lorenzo Ciullini; Giuseppe Pugliese
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

Review 4.  Hypophosphatasia.

Authors:  Agnès Linglart; Martin Biosse-Duplan
Journal:  Curr Osteoporos Rep       Date:  2016-06       Impact factor: 5.096

5.  Correlations of genotype and phenotype in hypophosphatasia.

Authors:  L Zurutuza; F Muller; J F Gibrat; A Taillandier; B Simon-Bouy; J L Serre; E Mornet
Journal:  Hum Mol Genet       Date:  1999-06       Impact factor: 6.150

6.  A novel combination of biallelic ALPL mutations associated with adult hypophosphatasia: A phenotype-genotype association and computational analysis study.

Authors:  Luciane Martins; Amanda Bandeira de Almeida; Elis Janaína Lira Dos Santos; Brian L Foster; Renato Assis Machado; Kamila Rosamilia Kantovitz; Ricardo D Coletta; Francisco H Nociti
Journal:  Bone       Date:  2019-05-08       Impact factor: 4.398

7.  Clinical, radiographic and biochemical characteristics of adult hypophosphatasia.

Authors:  T Schmidt; H Mussawy; T Rolvien; T Hawellek; J Hubert; W Rüther; M Amling; F Barvencik
Journal:  Osteoporos Int       Date:  2017-05-25       Impact factor: 4.507

8.  Clinical, pathological and genetic evaluations of Chinese patients with autosomal-dominant hypophosphatasia.

Authors:  Ke-wen Wei; Kun Xuan; Yan-li Liu; Jun Fang; Kun Ji; Xi Wang; Yan Jin; Shigeru Watanabe; Koji Watanabe; Takashi Ojihara
Journal:  Arch Oral Biol       Date:  2010-09-09       Impact factor: 2.633

9.  Current concepts in odontohypophosphatasia form of hypophosphatasia and report of two cases.

Authors:  Zhu-Yu Wang; Kai Zhang; Guang-Sen Zheng; Wei Qiao; Yu-Xiong Su
Journal:  BMC Oral Health       Date:  2016-08-17       Impact factor: 2.757

10.  Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles.

Authors:  Delphine Fauvert; Isabelle Brun-Heath; Anne-Sophie Lia-Baldini; Linda Bellazi; Agnès Taillandier; Jean-Louis Serre; Philippe de Mazancourt; Etienne Mornet
Journal:  BMC Med Genet       Date:  2009-06-06       Impact factor: 2.103

View more
  2 in total

Review 1.  Proposing a clinical algorithm for better diagnosis of hypophosphatasia in resource-limiting situations.

Authors:  Sreyanko Sadhukhan; Poonam Mehta; Singh Rajender; Sushil Kumar Gupta; Naibedya Chattopadhyay
Journal:  Osteoporos Int       Date:  2022-07-01       Impact factor: 4.507

2.  Clinical and genetic characteristics of hypophosphatasia in Chinese children.

Authors:  Meijuan Liu; Min Liu; Xuejun Liang; Di Wu; Wenjing Li; Chang Su; Bingyan Cao; Jiajia Chen; Chunxiu Gong
Journal:  Orphanet J Rare Dis       Date:  2021-04-07       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.